{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:06:51Z","timestamp":1788527211728,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,7]]},"DOI":"10.7759\/cureus.44865","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T20:10:19Z","timestamp":1694117419000},"source":"Crossref","is-referenced-by-count":5,"title":["Guardians of Immunity: Advances in Primary Immunodeficiency Disorders and Management"],"prefix":"10.7759","author":[{"given":"Nikhil Chowdary","family":"Peddi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravya","family":"Vuppalapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himabindu","family":"Sreenivasulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudheer kumar","family":"Muppalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apeksha","family":"Reddy Pulliahgaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244025","article-title":"B cells at the cross-roads of autoimmune diseases and auto-inflammatory syndromes","volume":"11","author":"Zouali M","year":"2022","unstructured":"Zouali M. B cells at the cross-roads of autoimmune diseases and auto-inflammatory syndromes. Cells. 2022, 11:4025. 10.3390\/cells11244025","journal-title":"Cells"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00389-09","article-title":"Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency","volume":"17","author":"Rezaei N","year":"2010","unstructured":"Rezaei N, Siadat SD, Aghamohammadi A, et al.. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency. Clin Vaccine Immunol. 2010, 17:524-8. 10.1128\/CVI.00389-09","journal-title":"Clin Vaccine Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204729","article-title":"Autoimmunity in primary immunodeficiency disorders: an updated review on pathogenic and clinical implications","volume":"10","author":"Costagliola G","year":"2021","unstructured":"Costagliola G, Cappelli S, Consolini R. Autoimmunity in primary immunodeficiency disorders: an updated review on pathogenic and clinical implications. J Clin Med. 2021, 10:4729. 10.3390\/jcm10204729","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.30.3.294","article-title":"Clinical implications of copy number variations in autoimmune disorders","volume":"30","author":"Yim SH","year":"2015","unstructured":"Yim SH, Jung SH, Chung B, Chung YJ. Clinical implications of copy number variations in autoimmune disorders. Korean J Intern Med. 2015, 30:294-304. 10.3904\/kjim.2015.30.3.294","journal-title":"Korean J Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020226","article-title":"New insights into the role of the complement system in human viral diseases","volume":"12","author":"Ostrycharz E","year":"2022","unstructured":"Ostrycharz E, Hukowska-Szematowicz B. New insights into the role of the complement system in human viral diseases. Biomolecules. 2022, 12:226. 10.3390\/biom12020226","journal-title":"Biomolecules"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18203\/2394-6040.ijcmph20161377","article-title":"Acute respiratory tract infections in children under 5 years of age in Upper Egypt","volume":"3","author":"Khalek EA","year":"2016","unstructured":"Khalek EA, Abdel-Salam DM. Acute respiratory tract infections in children under 5 years of age in Upper Egypt. Int J Community Med Public Health. 2016, 3:1161-6. 10.18203\/2394-6040.ijcmph20161377","journal-title":"Int J Community Med Public Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.15586\/aei.v49i2.62","article-title":"Novel BTK mutation in X-linked agammaglobulinemia: report of a 17-year-old male","volume":"49","author":"Shaka Z","year":"2021","unstructured":"Shaka Z, Mojtabavi H, Rayzan E, et al.. Novel BTK mutation in X-linked agammaglobulinemia: report of a 17-year-old male. Allergol Immunopathol (Madr). 2021, 49:80-3. 10.15586\/aei.v49i2.62","journal-title":"Allergol Immunopathol (Madr)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.11.027","article-title":"Immunoglobulin treatment in primary antibody deficiency","volume":"37","author":"Maarschalk-Ellerbroek LJ","year":"2011","unstructured":"Maarschalk-Ellerbroek LJ, Hoepelman IM, Ellerbroek PM. Immunoglobulin treatment in primary antibody deficiency. Int J Antimicrob Agents. 2011, 37:396-404. 10.1016\/j.ijantimicag.2010.11.027","journal-title":"Int J Antimicrob Agents"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00443","article-title":"Autologous stem-cell-based gene therapy for inherited disorders: state of the art and perspectives","volume":"7","author":"Staal FJ","year":"2019","unstructured":"Staal FJ, Aiuti A, Cavazzana M. Autologous stem-cell-based gene therapy for inherited disorders: state of the art and perspectives. Front Pediatr. 2019, 7:443. 10.3389\/fped.2019.00443","journal-title":"Front Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-265","article-title":"A novel Bruton's tyrosine kinase gene (BTK) missense mutation in a Chinese family with X-linked agammaglobulinemia","volume":"14","author":"Zheng B","year":"2014","unstructured":"Zheng B, Zhang Y, Jin Y, Yu H. A novel Bruton's tyrosine kinase gene (BTK) missense mutation in a Chinese family with X-linked agammaglobulinemia. BMC Pediatr. 2014, 14:265. 10.1186\/1471-2431-14-265","journal-title":"BMC Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030959","article-title":"Co-occurring X-linked agammaglobulinemia and X-linked chronic granulomatous disease: two isolated pathogenic variants in one patient","volume":"11","author":"Gunderman L","year":"2023","unstructured":"Gunderman L, Brown J, Chaudhury S, O'Gorman M, Fuleihan R, Khanolkar A, Ahmed A. Co-occurring X-linked agammaglobulinemia and X-linked chronic granulomatous disease: two isolated pathogenic variants in one patient. Biomedicines. 2023, 11:959. 10.3390\/biomedicines11030959","journal-title":"Biomedicines"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-020-00305-9","article-title":"The influence of evolutionary history on human health and disease","volume":"22","author":"Benton ML","year":"2021","unstructured":"Benton ML, Abraham A, LaBella AL, Abbot P, Rokas A, Capra JA. The influence of evolutionary history on human health and disease. Nat Rev Genet. 2021, 22:269-83. 10.1038\/s41576-020-00305-9","journal-title":"Nat Rev Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0452-9","article-title":"Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort \"Visages\"","volume":"11","author":"Bienvenu B","year":"2016","unstructured":"Bienvenu B, Cozon G, Hoarau C, et al.. Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort \"Visages\". Orphanet J Rare Dis. 2016, 11:10.1186\/s13023-016-0452-9","journal-title":"Orphanet J Rare Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.649112","article-title":"Innate mechanisms in selective IgA deficiency","volume":"12","author":"Zhang J","year":"2021","unstructured":"Zhang J, van Oostrom D, Li J, Savelkoul HF. Innate mechanisms in selective IgA deficiency. Front Immunol. 2021, 12:649112. 10.3389\/fimmu.2021.649112","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8632861","article-title":"The role of HLA in the association between IgA deficiency and celiac disease","volume":"2021","author":"Poddighe D","year":"2021","unstructured":"Poddighe D, Capittini C. The role of HLA in the association between IgA deficiency and celiac disease. 2021, 2021:10.1155\/2021\/8632861"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0939-9","article-title":"Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease","volume":"15","author":"Struja T","year":"2017","unstructured":"Struja T, Kutz A, Fischli S, Meier C, Mueller B, Recher M, Schuetz P. Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease. BMC Med. 2017, 15:174. 10.1186\/s12916-017-0939-9","journal-title":"BMC Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01056","article-title":"Selective IgM deficiency-an underestimated primary immunodeficiency","volume":"8","author":"Gupta S","year":"2017","unstructured":"Gupta S, Gupta A. Selective IgM deficiency-an underestimated primary immunodeficiency. Front Immunol. 2017, 8:1056. 10.3389\/fimmu.2017.01056","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-9-3","article-title":"Screening of functional and positional candidate genes in families with common variable immunodeficiency","volume":"9","author":"Salzer U","year":"2008","unstructured":"Salzer U, Neumann C, Thiel J, et al.. Screening of functional and positional candidate genes in families with common variable immunodeficiency. BMC Immunol. 2008, 9:3. 10.1186\/1471-2172-9-3","journal-title":"BMC Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3724630","article-title":"Common variable immunodeficiency with genetic defects identified by whole exome sequencing","volume":"2018","author":"Li R","year":"2018","unstructured":"Li R, Zheng Y, Li Y, et al.. Common variable immunodeficiency with genetic defects identified by whole exome sequencing. Biomed Res Int. 2018, 2018:1-7. 10.1155\/2018\/3724630","journal-title":"Biomed Res Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00636","article-title":"Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond","volume":"9","author":"de Valles-Ib\u00e1\u00f1ez G","year":"2018","unstructured":"de Valles-Ib\u00e1\u00f1ez G, Esteve-Sol\u00e9 A, Piquer M, et al.. Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond. Front Immunol. 2018, 9:636. 10.3389\/fimmu.2018.00636","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2018.77385","article-title":"In vitro chromosomal radiosensitivity in patients with common variable immunodeficiency","volume":"43","author":"Mahmoodi M","year":"2018","unstructured":"Mahmoodi M, Abolhassani H, Mozdarani H, et al.. In vitro chromosomal radiosensitivity in patients with common variable immunodeficiency. Cent Eur J Immunol. 2018, 43:155-61. 10.5114\/ceji.2018.77385","journal-title":"Cent Eur J Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.02.025","article-title":"Low circulating natural killer cell counts are associated with severe disease in patients with common variable immunodeficiency","volume":"6","author":"Ebbo M","year":"2016","unstructured":"Ebbo M, G\u00e9rard L, Carpentier S, et al.. Low circulating natural killer cell counts are associated with severe disease in patients with common variable immunodeficiency. EBioMedicine. 2016, 6:222-30. 10.1016\/j.ebiom.2016.02.025","journal-title":"EBioMedicine"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2012.04643.x","article-title":"T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections","volume":"170","author":"Bateman EA","year":"2012","unstructured":"Bateman EA, Ayers L, Sadler R, et al.. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol. 2012, 170:202-11. 10.1111\/j.1365-2249.2012.04643.x","journal-title":"Clin Exp Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05978-z","article-title":"Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases","volume":"21","author":"Zeng Q","year":"2021","unstructured":"Zeng Q, Jin Y, Yin G, et al.. Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases. BMC Infect Dis. 2021, 21:287. 10.1186\/s12879-021-05978-z","journal-title":"BMC Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211008073","article-title":"Delayed diagnosis of hyperimmunoglobulin E syndrome with STAT3 mutation in mainland China: a case report and literature review","volume":"49","author":"Fang J","year":"2021","unstructured":"Fang J, Yang Q, Pi B. Delayed diagnosis of hyperimmunoglobulin E syndrome with STAT3 mutation in mainland China: a case report and literature review. J Int Med Res. 2021, 49:10.1177\/03000605211008073","journal-title":"J Int Med Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3527480","article-title":"Evaluation of clinical and immunological characteristics of children with common variable immunodeficiency","volume":"2018","author":"Alkan G","year":"2018","unstructured":"Alkan G, Keles S, Reisli I. Evaluation of clinical and immunological characteristics of children with common variable immunodeficiency. Int J Pediatr. 2018, 2018:10.1155\/2018\/3527480","journal-title":"Int J Pediatr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.855200","article-title":"Immune dysregulation in pediatric common variable immunodeficiency: implications for the diagnostic approach","volume":"10","author":"Szczawi\u0144ska-Pop\u0142onyk A","year":"2022","unstructured":"Szczawi\u0144ska-Pop\u0142onyk A, Ta Polska-J\u00f3\u017awiak K, Schwartzmann E, Pop\u0142onyk N. Immune dysregulation in pediatric common variable immunodeficiency: implications for the diagnostic approach. Front Pediatr. 2022, 10:855200. 10.3389\/fped.2022.855200","journal-title":"Front Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jds.2012.10.005","article-title":"Thymoma with immunodeficiency with multiple recurrent oral herpetic infections","volume":"11","author":"Aydintug YS","year":"2016","unstructured":"Aydintug YS, Bayar GR, Ozkan A, Gunhan O, Musabak U. Thymoma with immunodeficiency with multiple recurrent oral herpetic infections. J Dent Sci. 2016, 11:103-6. 10.1016\/j.jds.2012.10.005","journal-title":"J Dent Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy163","article-title":"Expanding spectrum of Toxoplasma gondii: thymoma and toxoplasmic encephalitis","volume":"7","author":"Chastain DB","year":"2018","unstructured":"Chastain DB, Sams JI, Steele GM, Lowder LO, Franco-Paredes C. Expanding spectrum of Toxoplasma gondii: thymoma and toxoplasmic encephalitis. Open Forum Infect Dis. 2018, 7:10.1093\/ofid\/ofy163","journal-title":"Open Forum Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158332","article-title":"Dual nature of relationship between mycobacteria and cancer","volume":"15","author":"Fol M","year":"2021","unstructured":"Fol M, Kozi\u0144ski P, Kulesza J, Bia\u0142ecki P, Druszczy\u0144ska M. Dual nature of relationship between mycobacteria and cancer. Int J Mol Sci. 2021, 15:8332. 10.3390\/ijms22158332","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-264","article-title":"Characteristics and significance of T lymphocyte subsets in peripheral blood of osteosarcoma mice","volume":"11","author":"Liu Q","year":"2022","unstructured":"Liu Q, Xu R, Xu X, Huang Y, Ma Z. Characteristics and significance of T lymphocyte subsets in peripheral blood of osteosarcoma mice. Transl Cancer Res. 2022, 11:1503-9. 10.21037\/tcr-22-264","journal-title":"Transl Cancer Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080104","article-title":"Hearing loss in a mouse model of 22q11.2 deletion syndrome","volume":"8","author":"Fuchs JC","year":"2013","unstructured":"Fuchs JC, Zinnamon FA, Taylor RR, et al.. Hearing loss in a mouse model of 22q11.2 deletion syndrome. PLoS One. 2013, 8:e80104. 10.1371\/journal.pone.0080104","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.051144","article-title":"T cell immunodeficiency","volume":"61","author":"Edgar JD","year":"2008","unstructured":"Edgar JD. T cell immunodeficiency. J Clin Pathol. 2008, 61:988-93. 10.1136\/jcp.2007.051144","journal-title":"J Clin Pathol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37745","article-title":"DiGeorge syndrome with absence of speech: a rare case","volume":"15","author":"Jayaprakasan SK","year":"2023","unstructured":"Jayaprakasan SK, Nageye ME, Siddiqui A, Suero G, Pimentel Campillo J, Holder SS. DiGeorge syndrome with absence of speech: a rare case. Cureus. 2023, 15:e37745. 10.7759\/cureus.37745","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.140","article-title":"Comprehensive review of autoantibodies in patients with hyper-IgM syndrome","volume":"15","author":"Barbouche MR","year":"2018","unstructured":"Barbouche MR, Chen Q, Carbone M, et al.. Comprehensive review of autoantibodies in patients with hyper-IgM syndrome. Cell Mol Immunol. 2018, 15:610-17. 10.1038\/cmi.2017.140","journal-title":"Cell Mol Immunol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-001-0030-6","article-title":"The hyper IgM syndrome","volume":"1","author":"Fuleihan RL","year":"2001","unstructured":"Fuleihan RL. The hyper IgM syndrome. Curr Allergy Asthma Rep. 2001, 1:445-50. 10.1007\/s11882-001-0030-6","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02958","article-title":"The CD40-ATP-P2X (7) receptor pathway: cell to cell cross-talk to promote inflammation and programmed cell death of endothelial cells","volume":"10","author":"Subauste CS","year":"2019","unstructured":"Subauste CS. The CD40-ATP-P2X (7) receptor pathway: cell to cell cross-talk to promote inflammation and programmed cell death of endothelial cells. Front Immunol. 2019, 10:2958. 10.3389\/fimmu.2019.02958","journal-title":"Front Immunol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213353","article-title":"Clinical aspects of B cell immunodeficiencies: the past, the present and the future","volume":"11","author":"Ahmed A","year":"2022","unstructured":"Ahmed A, Lippner E, Khanolkar A. Clinical aspects of B cell immunodeficiencies: the past, the present and the future. Cells. 2022, 11:3353. 10.3390\/cells11213353","journal-title":"Cells"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103593","article-title":"The associations between immunity-related genes and breast cancer prognosis in Korean women","volume":"9","author":"Choi J","year":"2014","unstructured":"Choi J, Song N, Han S, et al.. The associations between immunity-related genes and breast cancer prognosis in Korean women. PLoS One. 2014, 9:e103593. 10.1371\/journal.pone.0103593","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(93)90040-y","article-title":"Primary T-cell immunodeficiencies","volume":"4","author":"Fischer A","year":"1993","unstructured":"Fischer A. Primary T-cell immunodeficiencies. Current opinion in immunology. 1993, 4:569-78. 10.1016\/0952-7915(93)90040-y","journal-title":"Current opinion in immunology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11144220","article-title":"Diagnostic challenges in patients with inborn errors of immunity with different manifestations of immune dysregulation","volume":"11","author":"Pieniawska-\u015amiech K","year":"2022","unstructured":"Pieniawska-\u015amiech K, Pasternak G, Lewandowicz-Uszy\u0144ska A, Jutel M. Diagnostic challenges in patients with inborn errors of immunity with different manifestations of immune dysregulation. J Clin Med. 2022, 11:4220. 10.3390\/jcm11144220","journal-title":"J Clin Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S232650","article-title":"Hematopoietic stem cell therapy for Wiskott-Aldrich syndrome: improved outcome and quality of life","volume":"12","author":"Mallhi KK","year":"2021","unstructured":"Mallhi KK, Petrovic A, Ochs HD. Hematopoietic stem cell therapy for Wiskott-Aldrich syndrome: improved outcome and quality of life. J Blood Med. 2021, 12:435-47. 10.2147\/JBM.S232650","journal-title":"J Blood Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17090-y","article-title":"Predicting and affecting response to cancer therapy based on pathway-level biomarkers","volume":"11","author":"Ben-Hamo R","year":"2020","unstructured":"Ben-Hamo R, Jacob Berger A, Gavert N, et al.. Predicting and affecting response to cancer therapy based on pathway-level biomarkers. Nat Commun. 2020, 11:3296. 10.1038\/s41467-020-17090-y","journal-title":"Nat Commun"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12849","article-title":"Severe combined immunodeficiency - an update","volume":"1356","author":"Cirillo E","year":"2015","unstructured":"Cirillo E, Giardino G, Gallo V, et al.. Severe combined immunodeficiency - an update. Ann N Y Acad Sci. 2015, 1356:90-106. 10.1111\/nyas.12849","journal-title":"Ann N Y Acad Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/ijns3020014","article-title":"Newborn screening for severe combined immunodeficiency-a history of the TREC assay","volume":"2","author":"Bausch-Jurken MT","year":"2017","unstructured":"Bausch-Jurken MT, Verbsky JW, Routes JM. Newborn screening for severe combined immunodeficiency-a history of the TREC assay. Int J Neonatal Screen. 2017, 2:14. 10.3390\/ijns3020014","journal-title":"Int J Neonatal Screen"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/nri3466","article-title":"Primary antibody deficiencies","volume":"13","author":"Durandy A","year":"2013","unstructured":"Durandy A, Kracker S, Fischer A. Primary antibody deficiencies. Nat Rev Immunol. 2013, 13:519-33. 10.1038\/nri3466","journal-title":"Nat Rev Immunol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-018-0290-5","article-title":"Primary immunodeficiency","volume":"14","author":"McCusker C","year":"2018","unstructured":"McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2018, 14:61. 10.1186\/s13223-018-0290-5","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02331","article-title":"Glycan microarray-assisted identification of IgG subclass targets in schistosomiasis","volume":"9","author":"Yang YY","year":"2018","unstructured":"Yang YY, van Diepen A, Brzezicka K, Reichardt NC, Hokke CH. Glycan microarray-assisted identification of IgG subclass targets in schistosomiasis. Front Immunol. 2018, 9:2331. 10.3389\/fimmu.2018.02331","journal-title":"Front Immunol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032414-112811","article-title":"How neutrophils kill microbes","volume":"32","author":"Segal AW","year":"2015","unstructured":"Segal AW. How neutrophils kill microbes. Annu Rev Immunol. 2015, 32:227-49. 10.1146\/annurev-immunol-032414-112811","journal-title":"Annu Rev Immunol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease: report on a national registry of 368 patients","volume":"79","author":"Winkelstein JA","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB Jr, et al.. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore). 2000, 79:155-69. 10.1097\/00005792-200005000-00003","journal-title":"Medicine (Baltimore)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-362-6_1","article-title":"Purification of human NK cell developmental intermediates from lymph nodes and tonsils","volume":"612","author":"Freud AG","year":"2010","unstructured":"Freud AG, Caligiuri MA. Purification of human NK cell developmental intermediates from lymph nodes and tonsils. Methods Mol Biol. 2010, 612:1-14. 10.1007\/978-1-60761-362-6_1","journal-title":"Methods Mol Biol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.10.015","article-title":"Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier","volume":"142","author":"Esensten JH","year":"2018","unstructured":"Esensten JH, Muller YD, Bluestone JA, Tang Q. Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier. J Allergy Clin Immunol. 2018, 142:1710-8. 10.1016\/j.jaci.2018.10.015","journal-title":"J Allergy Clin Immunol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnm.0000085066.58191.3d","article-title":"The role of nuclear medicine in the investigation of primary immunodeficiency diseases","volume":"7","author":"Lachmann RH","year":"2003","unstructured":"Lachmann RH, Peters AM. The role of nuclear medicine in the investigation of primary immunodeficiency diseases. Nucl Med Commun. 2003, 7:757-65. 10.1097\/01.mnm.0000085066.58191.3d","journal-title":"Nucl Med Commun"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/472040a","article-title":"Cardiovascular disease: the diet-microbe morbid union","volume":"472","author":"Rak K","year":"2011","unstructured":"Rak K, Rader DJ. Cardiovascular disease: the diet-microbe morbid union. Nature. 2011, 472:40-1. 10.1038\/472040a","journal-title":"Nature"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/s1357-2725(99)00002-5","article-title":"The function of the NADPH oxidase of phagocytes and its relationship to other NOXs in plants, invertebrates, and mammals","volume":"31","author":"Segal AW","year":"1999","unstructured":"Segal AW. The function of the NADPH oxidase of phagocytes and its relationship to other NOXs in plants, invertebrates, and mammals. Int J Biochem. 1999, 31:645-57. 10.1016\/s1357-2725(99)00002-5","journal-title":"Int J Biochem"},{"key":"ref56","article-title":"Familial hemophagocytic lymphohistiocytosis: towards a treatment protocol","volume":"356","author":"Liese JG","year":"2000","unstructured":"Liese JG, Renner ED, Stachel DK. Familial hemophagocytic lymphohistiocytosis: towards a treatment protocol. Eur J Pediatr. 2000, 356:978-80.","journal-title":"Eur J Pediatr"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-017-0682-2","article-title":"Novel insights into the pathophysiology of immunodeficiency-associated chronic rhinosinusitis","volume":"17","author":"Seger RA","year":"2017","unstructured":"Seger RA, Gungor T. Novel insights into the pathophysiology of immunodeficiency-associated chronic rhinosinusitis. Curr Allergy. 2017, 17:2. 10.1007\/s11882-017-0682-2","journal-title":"Curr Allergy"},{"key":"ref58","article-title":"New insights in the immunobiology of IL-1 family members","volume":"4","author":"van de Veerdonk FL","year":"2010","unstructured":"van de Veerdonk FL, Netea MG. New insights in the immunobiology of IL-1 family members. Front immunol. 2010, 4:167.","journal-title":"Front immunol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.07.003","article-title":"Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition","volume":"195","author":"Torigoe M","year":"2018","unstructured":"Torigoe M, Sakata K, Ishii A, Iwata S, Nakayamada S, Tanaka Y. Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition. Clin Immunol. 2018, 195:1-7. 10.1016\/j.clim.2018.07.003","journal-title":"Clin Immunol"},{"key":"ref60","article-title":"Leukocyte adhesion deficiency type 1-from gene to therapy","volume":"13","author":"Cale CM","year":"2017","unstructured":"Cale CM, Klein N. Leukocyte adhesion deficiency type 1-from gene to therapy. Expert Rev Clin Immunol. 2017, 13:889-903.","journal-title":"Expert Rev Clin Immunol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-46832-6_14","article-title":"Cell adhesion and leukocyte adhesion defects. In Immunodeficiency","volume":"2","author":"Etzioni A","year":"2007","unstructured":"Etzioni A, Harlan JM. Cell adhesion and leukocyte adhesion defects. In Immunodeficiency. Disorders. 2007, 2:550-61. 10.1007\/0-306-46832-6_14","journal-title":"Disorders"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.36.020185.000413","article-title":"Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150, 95 glycoproteins","volume":"36","author":"Anderson DC","year":"1985","unstructured":"Anderson DC, Springer TA, Ueda Y. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150, 95 glycoproteins. Annu Rev Med. 1985, 36:53-65. 10.1146\/annurev.me.36.020185.000413","journal-title":"Annu Rev Med"},{"key":"ref63","article-title":"Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options","volume":"81","author":"Etzioni A","year":"2003","unstructured":"Etzioni A. Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options. Adv Immunol. 2003, 81:163-210.","journal-title":"Adv Immunol"},{"key":"ref64","article-title":"Natural history and early diagnosis of LAD-1\/variant syndrome","volume":"3","author":"Kuijpers TW","year":"2007","unstructured":"Kuijpers TW, van Bruggen R, Kamerbeek N, et al.. Natural history and early diagnosis of LAD-1\/variant syndrome. Blood. 2007, 3:909-18.","journal-title":"Blood"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3283323622","article-title":"Advances in leukocyte adhesion deficiency type 1","volume":"17","author":"Hidalgo A","year":"2010","unstructured":"Hidalgo A, Ma S. Advances in leukocyte adhesion deficiency type 1. Curr Opin Hematol. 2010, 17:15-21. 10.1097\/MOH.0b013e3283323622","journal-title":"Curr Opin Hematol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin D","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010, 11:785-97. 10.1038\/ni.1923","journal-title":"Nat Immunol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement","volume":"344","author":"Walport MJ","year":"2001","unstructured":"Walport MJ. Complement. N Engl J Med. 2001, 344:1058-66. 10.1056\/NEJM200104053441406","journal-title":"N Engl J Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.11.5867","article-title":"Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane","volume":"9","author":"Fearon DT","year":"1979","unstructured":"Fearon DT. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci. 1979, 9:4360-4. 10.1073\/pnas.76.11.5867","journal-title":"Proc Natl Acad Sci"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris M","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, et al.. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010, 5:1844-59. 10.2215\/CJN.02210310","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-84628-661-5_28","article-title":"Complement in the pathogenesis of systemic lupus erythematosus","author":"Bowness P","year":"2006","unstructured":"Bowness P, Davies KA. Complement in the pathogenesis of systemic lupus erythematosus. Lupus (ed): Springer, 306-13; 2006. 10.1007\/978-1-84628-661-5_28"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401003","article-title":"Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease","volume":"340","author":"Kuijpers TW","year":"1999","unstructured":"Kuijpers TW, Weening RS, van Gijn M, Nagelkerke SQ, Hack CE. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med. 1999, 340:757-63. 10.1056\/NEJM199903113401003","journal-title":"N Engl J Med"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2012.04573.x","article-title":"Functionality of CD4+ and CD8+ T cells from tonsillar tissue","volume":"168","author":"Sada-Ovalle I","year":"2012","unstructured":"Sada-Ovalle I, Talayero A, Chav\u00e9z-Gal\u00e1n L, Barrera L, Castorena-Maldonado A, Soda-Merhy A, Torre-Bouscoulet L. Functionality of CD4+ and CD8+ T cells from tonsillar tissue. Clin Exp Immunol. 2012, 168:200-6. 10.1111\/j.1365-2249.2012.04573.x","journal-title":"Clin Exp Immunol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic lymphohistiocytosis","volume":"13","author":"Al-Samkari H","year":"2018","unstructured":"Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 2018, 13:27-49. 10.1146\/annurev-pathol-020117-043625","journal-title":"Annu Rev Pathol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12791","article-title":"Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases","volume":"291","author":"Latour S","year":"2019","unstructured":"Latour S, Fischer A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases. Immunol Rev. 2019, 291:174-89. 10.1111\/imr.12791","journal-title":"Immunol Rev"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8466-y","article-title":"Updated understanding of autoimmune lymphoproliferative syndrome (ALPS)","volume":"50","author":"Li P","year":"2016","unstructured":"Li P, Huang P, Yang Y, Hao M, Peng H, Li F. Updated understanding of autoimmune lymphoproliferative syndrome (ALPS). Clin Rev Allergy Immunol. 2016, 50:55-63. 10.1007\/s12016-015-8466-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira JB","year":"2010","unstructured":"Oliveira JB, Bleesing JJ, Dianzani U, et al.. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010, 116:e35-40. 10.1182\/blood-2010-04-280347","journal-title":"Blood"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.612760","article-title":"IPEX syndrome: Improved knowledge of immune pathogenesis empowers diagnosis","volume":"9","author":"Barzaghi F","year":"2021","unstructured":"Barzaghi F, Passerini L. IPEX syndrome: Improved knowledge of immune pathogenesis empowers diagnosis. Front Pediatr. 2021, 9:612760. 10.3389\/fped.2021.612760","journal-title":"Front Pediatr"},{"key":"ref79","article-title":"IPEX Syndrome","author":"Tan QK","year":"2004","unstructured":"Tan QK, Louie RJ, Sleasman JW. IPEX Syndrome. Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (ed): GeneReviews, Seattle (WA); 2004."},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1176","article-title":"APECED mutations in the autoimmune regulator (AIRE) gene","volume":"18","author":"Heino M","year":"2001","unstructured":"Heino M, Peterson P, Kudoh J, Shimizu N, Antonarakis SE, Scott HS, Krohn K. APECED mutations in the autoimmune regulator (AIRE) gene. Hum Mutat. 2001, 18:205-11. 10.1002\/humu.1176","journal-title":"Hum Mutat"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-007-0024-0","article-title":"Common variable immune deficiency: reviews, continued puzzles, and a new registry","volume":"38","author":"Cunningham-Rundles C","year":"2007","unstructured":"Cunningham-Rundles C, Knight AK. Common variable immune deficiency: reviews, continued puzzles, and a new registry. Immunol Res. 2007, 38:78-86. 10.1007\/s12026-007-0024-0","journal-title":"Immunol Res"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.DMIH2-0026-2016","article-title":"Overview of Infections in the Immunocompromised Host","volume":"4","author":"Dropulic LK","year":"2016","unstructured":"Dropulic LK, Lederman HM. Overview of Infections in the Immunocompromised Host. Microbiol Spectr. 2016, 4:10.1128\/microbiolspec.DMIH2-0026-2016","journal-title":"Microbiol Spectr"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2010.05.001","article-title":"Diagnosis and treatment of primary immunodeficiency disease: the role of the otolaryngologist","volume":"32","author":"Wasserman RL","year":"2011","unstructured":"Wasserman RL, Manning SC. Diagnosis and treatment of primary immunodeficiency disease: the role of the otolaryngologist. Am J Otolaryngol. 2011, 32:329-37. 10.1016\/j.amjoto.2010.05.001","journal-title":"Am J Otolaryngol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.2001.00456.x","article-title":"Investigation for immunodeficiency in patients with recurrent ENT infections","volume":"26","author":"Cooney TR","year":"2001","unstructured":"Cooney TR, Huissoon AP, Powell RJ, Jones NS. Investigation for immunodeficiency in patients with recurrent ENT infections. Clin Otolaryngol Allied Sci. 2001, 26:184-8. 10.1046\/j.1365-2273.2001.00456.x","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100324","article-title":"Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement","volume":"9","author":"Duraisingham SS","year":"2014","unstructured":"Duraisingham SS, Buckland M, Dempster J, Lorenzo L, Grigoriadou S, Longhurst HJ. Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement. PLoS One. 2014, 9:e100324. 10.1371\/journal.pone.0100324","journal-title":"PLoS One"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.902314","article-title":"Secondary antibody deficiency","volume":"10","author":"Duraisingham SS","year":"2014","unstructured":"Duraisingham SS, Buckland MS, Grigoriadou S, Longhurst HJ. Secondary antibody deficiency. Expert Rev Clin Immunol. 2014, 10:583-91. 10.1586\/1744666X.2014.902314","journal-title":"Expert Rev Clin Immunol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-6-571","article-title":"Secondary antibody deficiency - causes and approach to diagnosis","volume":"16","author":"Srivastava S","year":"2016","unstructured":"Srivastava S, Wood P. Secondary antibody deficiency - causes and approach to diagnosis. Clin Med (Lond). 2016, 16:571-6. 10.7861\/clinmedicine.16-6-571","journal-title":"Clin Med (Lond)"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.08.043","article-title":"Laboratory evaluation of primary immunodeficiencies","volume":"125","author":"Oliveira JB","year":"2010","unstructured":"Oliveira JB, Fleisher TA. Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol. 2010, 125:S297-305. 10.1016\/j.jaci.2009.08.043","journal-title":"J Allergy Clin Immunol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla FA","year":"2015","unstructured":"Bonilla FA, Khan DA, Ballas ZK, et al.. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015, 136:1186-205.e1-78. 10.1016\/j.jaci.2015.04.049","journal-title":"J Allergy Clin Immunol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1310","article-title":"Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases","volume":"137","author":"Al-Mousa H","year":"2016","unstructured":"Al-Mousa H, Abouelhoda M, Monies DM, et al.. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases. J Allergy Clin Immunol. 2016, 137:1780-7. 10.1016\/j.jaci.2015.12.1310","journal-title":"J Allergy Clin Immunol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2009.09.011","article-title":"The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline","volume":"24 Suppl 1","author":"Shehata N","year":"2010","unstructured":"Shehata N, Palda V, Bowen T, et al.. The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. Transfus Med Rev. 2010, 24 Suppl 1:S28-50. 10.1016\/j.tmrv.2009.09.011","journal-title":"Transfus Med Rev"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00627","article-title":"Primary immune deficiencies - principles of care","volume":"5","author":"Chapel H","year":"2014","unstructured":"Chapel H, Prevot J, Gaspar HB, Espa\u00f1ol T, Bonilla FA, Solis L, Drabwell J. Primary immune deficiencies - principles of care. Front Immunol. 2014, 5:627. 10.3389\/fimmu.2014.00627","journal-title":"Front Immunol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e328332be33","article-title":"Antimicrobial prophylaxis for primary immunodeficiencies","volume":"9","author":"Freeman AF","year":"2009","unstructured":"Freeman AF, Holland SM. Antimicrobial prophylaxis for primary immunodeficiencies. Curr Opin Allergy Clin Immunol. 2009, 9:525-30. 10.1097\/ACI.0b013e328332be33","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.01.051","article-title":"Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies","volume":"144","author":"Milito C","year":"2019","unstructured":"Milito C, Pulvirenti F, Cinetto F, et al.. Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies. J Allergy Clin Immunol. 2019, 144:584-93.e7. 10.1016\/j.jaci.2019.01.051","journal-title":"J Allergy Clin Immunol"},{"key":"ref95","article-title":"Management of the patient with IgG subclass deficiency and\/or selective antibody deficiency","volume":"70","author":"Herrod HG","year":"1993","unstructured":"Herrod HG. Management of the patient with IgG subclass deficiency and\/or selective antibody deficiency. Ann Allergy. 1993, 70:3-8.","journal-title":"Ann Allergy"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2020.10.005","article-title":"Treatment of patients with immunodeficiency: medication, gene therapy, and transplantation","volume":"97 Suppl 1","author":"Segundo GR","year":"2021","unstructured":"Segundo GR, Condino-Neto A. Treatment of patients with immunodeficiency: medication, gene therapy, and transplantation. J Pediatr (Rio J). 2021, 97 Suppl 1:S17-23. 10.1016\/j.jped.2020.10.005","journal-title":"J Pediatr (Rio J)"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange JS","year":"2006","unstructured":"Orange JS, Hossny EM, Weiler CR, et al.. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006, 117:S525-53. 10.1016\/j.jaci.2006.01.015","journal-title":"J Allergy Clin Immunol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein JA","year":"2003","unstructured":"Winkelstein JA, Marino MC, Ochs H, et al.. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003, 82:373-84. 10.1097\/01.md.0000100046.06009.b0","journal-title":"Medicine"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives","volume":"7","author":"Castagnoli R","year":"2019","unstructured":"Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD. Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives. Front Pediatr. 2019, 7:295. 10.3389\/fped.2019.00295","journal-title":"Front Pediatr"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(68)92672-x","article-title":"Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome","volume":"292","author":"Bach FH","year":"1968","unstructured":"Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968, 292:1364-6. 10.1016\/s0140-6736(68)92672-x","journal-title":"Lancet"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study","volume":"130","author":"Heimall J","year":"2017","unstructured":"Heimall J, Logan BR, Cowan MJ, et al.. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017, 130:2718-27. 10.1182\/blood-2017-05-781849","journal-title":"Blood"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai SY","year":"2014","unstructured":"Pai SY, Logan BR, Griffith LM, et al.. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med. 2014, 371:434-46. 10.1056\/NEJMoa1401177","journal-title":"N Engl J Med"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-022-08950-0","article-title":"The treatment of primary immune deficiencies: lessons learned and future opportunities","volume":"65","author":"Paris K","year":"2023","unstructured":"Paris K, Wall LA. The treatment of primary immune deficiencies: lessons learned and future opportunities. Clin Rev Allergy Immunol. 2023, 65:19-30. 10.1007\/s12016-022-08950-0","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery AR","year":"2010","unstructured":"Gennery AR, Slatter MA, Grandin L, et al.. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?. J Allergy Clin Immunol. 2010, 126:602-10.e1-11. 10.1016\/j.jaci.2010.06.015","journal-title":"J Allergy Clin Immunol"},{"key":"ref105","article-title":"Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients","volume":"91","author":"Haddad E","year":"1998","unstructured":"Haddad E, Landais P, Friedrich W, et al.. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood. 1998, 91:3646-53.","journal-title":"Blood"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.05.031","article-title":"Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation","volume":"132","author":"Cole T","year":"2013","unstructured":"Cole T, Pearce MS, Cant AJ, Cale CM, Goldblatt D, Gennery AR. Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013, 132:1150-5. 10.1016\/j.jaci.2013.05.031","journal-title":"J Allergy Clin Immunol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"G\u00fcng\u00f6r T","year":"2014","unstructured":"G\u00fcng\u00f6r T, Teira P, Slatter M, et al.. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014, 383:P436-48. 10.1016\/S0140-6736(13)62069-3","journal-title":"Lancet"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2019000052","article-title":"Treatment of primary immunodeficiency with allogeneic transplant and gene therapy","volume":"2019","author":"Pai SY","year":"2019","unstructured":"Pai SY. Treatment of primary immunodeficiency with allogeneic transplant and gene therapy. Hematology Am Soc Hematol Educ Program. 2019, 2019:457-65. 10.1182\/hematology.2019000052","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2018.08.003","article-title":"Update on advances in hematopoietic cell transplantation for primary immunodeficiency disorders","volume":"39","author":"Shamriz O","year":"2019","unstructured":"Shamriz O, Chandrakasan S. Update on advances in hematopoietic cell transplantation for primary immunodeficiency disorders. Immunol Allergy Clin North Am. 2019, 39:113-28. 10.1016\/j.iac.2018.08.003","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1038\/87687","article-title":"CD45: new jobs for an old acquaintance","volume":"2","author":"Penninger JM","year":"2001","unstructured":"Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ. CD45: new jobs for an old acquaintance. Nat Immunol. 2001, 2:389-96. 10.1038\/87687","journal-title":"Nat Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185327-guardians-of-immunity-advances-in-primary-immunodeficiency-disorders-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:06:54Z","timestamp":1707491214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185327-guardians-of-immunity-advances-in-primary-immunodeficiency-disorders-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":110,"URL":"https:\/\/doi.org\/10.7759\/cureus.44865","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,7]]}}}